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AP-SWATH Reveals Direct Involvement of VCP/
p97 in Integrated Stress Response Signaling
Through Facilitating CReP/PPP1R15B
Degradation*□S
Julia Hu¨lsmann‡, Bojana Kravic‡, Matthias Weith‡, Matthias Gstaiger§,
Ruedi Aebersold§¶, Ben C. Collins§, and Hemmo Meyer‡
The ubiquitin-directed AAA-ATPase VCP/p97 facilitates
degradation of damaged or misfolded proteins in diverse
cellular stress response pathways. Resolving the com-
plexity of its interactions with partner and substrate pro-
teins and understanding its links to stress signaling is
therefore a major challenge. Here, we used affinity-puri-
fication SWATH mass spectrometry (AP-SWATH) to
identify proteins that specifically interact with the sub-
strate-trapping mutant, p97-E578Q. AP-SWATH identified
differential interactions over a large detection range from
abundant p97 cofactors to pathway-specific partners and
individual ligases such as RNF185 and MUL1 that were
trapped in p97-E578Q complexes. In addition, we identi-
fied various substrate proteins and candidates including
the PP1 regulator CReP/PPP1R15B that dephosphory-
lates eIF2 and thus counteracts attenuation of transla-
tion by stress-kinases. We provide evidence that p97 with
its Ufd1-Npl4 adapter ensures rapid constitutive turnover
and balanced levels of CReP in unperturbed cells. More-
over, we show that p97-mediated degradation, together
with a reduction in CReP synthesis, is essential for timely
stress-induced reduction of CReP levels and, conse-
quently, for robust eIF2 phosphorylation to enforce the
stress response. Thus, our results demonstrate that p97
not only facilitates bulk degradation of misfolded proteins
upon stress, but also directly modulates the integrated
stress response at the level of signaling. Molecular &
Cellular Proteomics 17: 10.1074/mcp.RA117.000471,
1295–1307, 2018.
Key elements of the response to cellular stresses that
threaten protein homeostasis include the induction of protein
folding factors such as chaperones, the efficient clearance of
terminally misfolded proteins and the attenuation of protein
synthesis (1). Inhibition of translation is achieved by various
stress kinases including the endoplasmic reticulum (ER)1
stress sensor PERK (2–4). As elements of the integrated
stress response (ISR) these kinases converge on phosphoryl-
ating the eukaryotic initiation factor 2 alpha (eIF2) at ser-
ine-51 to block global translation at the ribosome (5, 6). The
phosphorylation of eIF2 is antagonized by protein phospha-
tase-1 (PP1) complexes with one of two alternative regulatory
subunits. Gadd34/PPP1R15A is induced after stress, and
shuts down the stress response to resume protein synthesis
(7, 8). In contrast, CReP/PPP1R15B is constitutively ex-
pressed and balances eIF2 phosphorylation in unperturbed
cells (9).
The clearance of misfolded proteins, on the other hand, is
mediated by the ubiquitin-proteasome system (UPS) and au-
tophagy. The AAA-type ATPase Valosin-containing protein
(VCP)/p97 (also called Cdc48 or Ter94) is a critical bottleneck
in these processes (10, 11). It helps mobilize and unfold large
cohorts of ubiquitin-modified substrates to facilitate their deg-
radation in the proteasome in diverse pathways and compart-
ments ranging from ER-associated degradation (ERAD),
ribosomal quality control, mitochondrial stress response to
macroautophagy and degradation of chromatin-associated
proteins (11–14). Consistent with this, missense mutations in
p97 are associated with multisystem proteinopathy-1 in hu-
mans (also called IBMPFD/ALS) comprising an inclusion body
myopathy, Paget’s disease of bone, fronto-temporal demen-
tia and amyotrophic lateral sclerosis (15, 16). Moreover, p97
inhibitors are being explored as cancer drugs based on the
rationale that they induce a proteostasis crisis and cell death
in cancer cells with extra burden of misfolded proteins, and
first inhibitors are moving into clinical trials (17, 18).
p97 has two AAA domains, D1 and D2, that form two
stacked hexameric rings around a central channel (13). ATP
hydrolysis in D2 is most critical for unfolding (19–21). Con-
sistent with this, a variant harboring the E578Q mutation in the
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Walker B motif of D2 traps substrate proteins (13, 20). A host
of accessory proteins cooperate with p97. They include more
than thirty cofactor proteins that directly interact with the
regulatory N-domain or the C-terminal tail of p97 through
dedicated interaction domains, and assist p97 as ubiquitin
adapters, targeting factors or regulators (16, 22). However, it
is often unclear if and how binding of accessory factors in
diverse pathways is linked to substrate unfolding. A second
challenge is the identification of critical substrate proteins.
Although p97 targets large cohorts of misfolded proteins in
established stress pathways, only few regulatory degradation
substrates are known so far, and it is unclear if and how
p97 governs stress signaling by directly targeting stress
regulators.
To tackle the complexity of p97 interactions, we compared
p97 wild-type (wt) complexes with complexes containing the
p97 substrate-trapping mutant p97-E578Q using affinity pu-
rification followed by SWATH mass spectrometry (AP-
SWATH). AP-SWATH identified and quantified differential in-
teractions over a large range of interactor abundance. This
revealed subsets of cofactors, accessory factors and ubiqui-
tin ligases that were specifically enriched with p97-E578Q
indicating that their binding is linked to substrate unfolding. In
addition, we isolated a set of p97 substrate candidates.
Among them, we identified the PP1 regulator CReP/
PPP1R15B as a direct target of the p97-Ufd1-Npl4 cofactor
complex. We provide evidence that p97 balances CReP levels
in unperturbed cells. Moreover, we demonstrate that p97-
mediated degradation of CReP is an important element for the
timely reduction of CReP levels after severe stresses and thus
for ensuring robust eIF2 phosphorylation to enforce the ISR.
EXPERIMENTAL PROCEDURES
Plasmids—pcDNA5-p97-WT/E578Q-myc-strep/FRT/TO were de-
scribed previously (23). Expression constructs coding for RNF185
and MUL1 with C-terminal GFP tag were generated by gateway
cloning (Invitrogen, Carlsbad, CA) using human ORFeome library vec-
tors (hORFeome V5.1, Open Biosystems; internal IDs: 10236
(RNF185), 6868 (MUL1)). LR recombination was performed with
the pcDNA5/FRT/TO/GFP/GW destination vector obtained from
pcDNA5/FRT/TO/cSH/GW (24) by substitution of the strep-HA with
GFP coding sequence via Gibson Assembly cloning. Full length
UBE4B cDNA was amplified from an IMAGE clone (ID 7939541)
and cloned into pEGFP-C1 using XhoI and BamHI. Flag-tagged
PPP1R15B-mCherry (FLAG_hPPP1R15B_4–713_mCherry_UK1298)
was a gift from David Ron (Addgene plasmid # 80707) (25).
Cell Culture and Transfections—HEK293 and HeLa cells were cul-
tured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 10% fetal calf serum (FCS) in the presence of penicillin/strepto-
mycin. Stable inducible HEK293 cell lines expressing p97-WT-myc-
strep or p97-EQ-myc-strep were generated with the Flp-In T-Rex
system (Invitrogen) according to the manufacturer’s protocol. Stable
cell lines were maintained in culture medium as described above,
supplemented with 15 g/ml blasticidin S and 100 g/ml hygromycin
B. Expression was induced with 1 g/ml doxycycline. HEK293 and
HeLa cells were transiently transfected with plasmids using JetPRIME
(Polyplus, Illkirch-Graffenstaden, France) or Lipofectamine2000 re-
agents (Invitrogen), respectively, 1 day after seeding. Medium was
changed 4 h after transfection. Cells were analyzed after 24 h.
RNAi—The siRNA oligomers targeting Ufd1 (#1: GUGGCCACCUA-
CUCCAAAUTT; #2: CUACAAAGAACCCGAAAGATT), p47 (AGCCAG-
CUCUUCCAUCUUATT), -TrCP 1/2 (GUGGAAUUUGUGGAACAU-
CTT), CReP (AAGGGAUGGAUGCAGGUUCCATT) and a nontargeting
control oligomer (UUCUCCGAACGUGUCACGUTT) were purchased
from Microsynth (Balgach, Switzerland) and were characterized pre-
viously (9, 23, 26, 27). Reverse transfection into HEK293 cells was
performed with 10 nM final concentration using Lipofectamine
RNAiMax (Invitrogen). Cells were analyzed after 48 h or as indicated.
Pharmacological and Stress Treatments—For cycloheximide chase
experiments, HEK293 cells were treated with 50 g/ml CHX (Sigma,
St. Louis, MO) for indicated times. p97 and proteasome inhibitors
were added for 1 h (or as indicated) using NMS-873 (5 M; Sigma) and
CB-5083 (5 M; Selleckchem, Houston, TX) or MG132 (20 M; Merck
1 The abbreviations used are: ER, endoplasmic reticulum; AAA,
ATPases associated with diverse cellular activities; ALS, amyotrophic
lateral sclerosis; AMFR, Autocrine motility factor receptor; AP, affinity
purification; As, sodium arsenite; ASPSCR1, Alveolar soft part
sarcoma chromosomal region candidate gene 1 protein; ATXN3,
Ataxin-3; BCA, bicinchoninic acid; -TrCP, beta-transducin repeat-
containing protein; cdc, cell division cycle; Chk1, checkpoint ki-
nase-1; CHX, cycloheximide; CReP, constitutive repressor of eIF2
phosphorylation; CUL, cullin; DDA, data dependent acquisition; DOX,
doxycycline; E3, ubiquitin ligase; EGF, epidermal growth factor;
eIF2, eukaryotic translation initiation factor 2A; EPSTI1, Epithelial-
stromal interaction protein 1; ERAD, ER-associated degradation; EQ,
ATPase-deficient p97-E578Q mutant; exp, exposure; FAF, Fas-asso-
ciated factor; FDR, False discovery rate; FEM1B, Fem-1 Homolog B;
GADD34, Growth arrest and DNA damage-inducible protein; GFP,
green fluorescent protein; GLUL, glutamine synthetase; HEK, human
embryonic kidney; HRP, horseradish peroxidase; IBMPFD, inclusion
body myopathy with early-onset Paget disease and frontotemporal
dementia; IkBa, NF-kappa-B inhibitor alpha; IP, immunoprecipitation;
iRD, indexed retention time; ISR, integrated stress response; log
logarithm; MUL1, Mitochondrial ubiquitin ligase activator of NFKB 1;
MYO5C, Unconventional myosin-Vc; NFkB, nuclear factor NF-kap-
pa-B; NGLY1, N-glycanase 1; Npl4, Nuclear protein localization pro-
tein 4 homolog; NSFL1C, N-ethylmaleimide-sensitive factor (NSF)L1
cofactor; OTU, ovarian tumor DUB domain; PD, pulldown; PERK,
PKR-like ER kinase; PKR, protein kinase repressor; PLAA, phospho-
lipase A-2-activating protein; PP1, Protein phosphatase-1; ppm,
parts per million; PPP1R, Protein phosphatase 1 regulatory subunit;
psm peptide spectrum match; RNF31, RING finger protein 31;
RNF185, RING finger protein 185; SCF, Skp1–Cullin–F-box; SEL1L,
Protein sel-1 homolog 1; s.e.m., standard error of the mean; SEP,
Shp1-eyc-p47 domain; SH3KBP1, SH3 Domain Containing Kinase
Binding Protein 1; SHKBP1, SH3KBP1-binding protein 1; siRNA,
small interfering RNA; SPRTN, SprT-like domain-containing protein
Spartan; strep streptavidin; SVIP, small VCP/p97-interacting protein;
SWATH, Sequential Window Acquisition of all Theoretical Mass Spec-
tra; Tg, thapsigargin; Tm, tunicamycin; TRAFD1, TRAF-type zinc fin-
ger domain containing protein 1; TRIC, TRansfer of Identification
Confidence; Ub, ubiquitin; UBAC2, Ubiquitin-associated domain-
containing protein 2; UBX, ubiquitin domain-X; UBE, ubiquitin-conju-
gating enzyme; UBXD, UBX domain-containing protein; Ufd, Ubiquitin
fusion degradation protein; UPS, ubiquitin-proteasome system; UT,
untreated; VCP, Valosin-containing protein; VCPIP1, Valosin-con-
taining protein p97/p47 complex-interacting protein 1; WLS, wnt-
less Wnt ligand secretion mediator; WT, wild-type; YOD1, yeast
OTU1 deubiquitinating enzyme 1 homolog; ZFAND2B, AN1-type
zinc finger protein 2B.
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Millipore, Darmstadt, Germany). For pharmacological stress induc-
tion, cells were exposed to 0.5 mM sodium arsenite, 50 g/ml tuni-
camycin (both Sigma) or 10 M thapsigargin (Diagonal, Mu¨nster,
Germanyl) for the indicated period. UV irradiation was performed by
removing medium from adherent cells and covering them in 37 °C
PBS. Cells were exposed to 300 J/m2 UV-C (254 nm) and PBS was
replaced by the previously removed media (for simultaneous inhibitor
treatment drugs were added directly after UV exposure). Cells were
analyzed at indicated time points after irradiation.
Immunoprecipitation and Immunoblotting—Cells were harvested
24 h after transient transfection and/or 20 h after induction with
doxycycline in IP buffer (150 mM KCl, 5 mM MgCl2, 50 mM Tris-HCl pH
7.4, 1% Triton X-100, 5% glycerol, 2 mM -mercaptoethanol supple-
mented with cOmplete EDTA-free protease inhibitors and PhosSTOP
(Roche, Basel, Switzerland)) and incubated on ice for 20 min. To
stabilize ubiquitination of CReP, the IP buffer was additionally sup-
plemented with 10 mM N-ethylmaleimide (Sigma). Lysates were
cleared by centrifugation (15 min, 17,000  g, 4 °C) and protein
concentration was determined in a BCA assay (Interchim, Montlucon,
France). For degradation assays, 25 g protein/sample were directly
resolved by SDS-PAGE and analyzed by Western blotting. Immuno-
precipitation and pulldown experiments were performed using Strep-
Tactin Sepharose (IBA BioTAGnology, Go¨ttingen, Germany), anti-
GFP nanobodies or specific antibodies and Protein G Sepharose (GE
Healthcare, Chicago, IL). Affinity purifications were performed for 2 h
at 4 °C rotating (strep-/GFP pulldown assays) or 2 h incubation with
the indicated primary antibodies on ice and additionally with Protein
G Sepharose for 1 h rotating at 4 °C to capture antigen-antibody
complexes. Beads were washed five times in IP buffer and eluted by
boiling in 2  SDS sample buffer. Samples were resolved by SDS-
PAGE and transferred to nitrocellulose membranes (Amersham Bio-
sciences, GE Healthcare). Immunoblot analysis was performed with
the indicated antibodies and visualized by chemiluminescence.
Quantification of Western Blots was performed by capturing antibody
signal either with a CCD camera (Amersham Biosciences Imager 600
(GE Healthcare)) and/or with an Odyssey CLx fluorescence reader
(LI-COR, Lincoln, NE) whereas image analysis was performed with the
TotalLab Quant software.
Fluorescence Microscopy—HeLa or HEK293 cells were fixed in 4%
paraformaldehyde, permeabilized with 0.1% Triton X-100 in PBS,
blocked by 3% bovine serum albumin in PBS containing 0.1% Triton
X-100 and 0.1% saponin. Confocal laser scanning microscopy was
performed on a TCS SP5 AOBS system equipped with standard PMT
detectors as well as sensitive HyD detectors (Leica Microsystems,
Wetzlar, Germany). Images were acquired using an HCX PL APO
63/1.4NA oil-immersion objective. Lasers used for excitation were
DPSS 561 nm (Alexa Fluor® 568, mCherry), Ar 488 nm (GFP) and
Diode 405 nm (DAPI). Acquisition and hardware was controlled by
LAS AF software (Leica Microsystems).
Antibodies—Antibodies used for Western blot analysis against p97
(HME8), UBXD1 (E43), Ufd1 (HME14), Npl4 (HME18), p47 (HME22)
and p37 (20880) were described previously (23, 28, 29). Anti-UBXD4
(25272) antibody was raised in rabbits against purified recombinant
GST-tagged proteins (BioGenes, Berlin, Germany). Anti-UBXD7
(S409D) antibody was generated and obtained from the MRCprotein
phosphorylation unit, Dundee (G. Alexandru). Anti-PLAA (Y102) was
purchased from Abcam (Cambridge, UK). Mouse anti-ubiquitin (clone
FK2, 04–263) and rabbit anti-Histone H3 (06–755) were purchased
from Millipore. Anti-PPP1R15B (CReP) was from Proteintech (Rose-
mont, IL) (14634–1-AP). Rabbit monoclonal anti-phosphoS51-eIF2
(#3398) and anti-phosphoS317Chk1 (#2344) antibodies were pur-
chased from Cell Signaling (Danvers, MA). Mouse monoclonal anti-
eIF2 (D-3, sc-133132) and anti-HSC 70 (B-6, sc-7298) antibodies
were from Santa Cruz Biotechnology (Dallas, TX). Monoclonal anti-
Flag M2 (F3165), anti-myc (M4439), anti--tubulin (T5168) and anti-
GAPDH (G8795) were from Sigma-Aldrich. Anti-GFP was from Roche.
HRP-coupled secondary antibodies were purchased from Bio-Rad
(Hercules, CA) and IRDye®-conjugated secondary antibodies from
LI-COR. Antibodies used for immunofluorescence stainings were an-
ti-Tom20 (Santa Cruz, sc-11415) and anti-Calnexin (Enzo Life Sci-
ences, ADI-SPA-860-F), and secondary antibodies conjugated to Al-
exa Fluor® 568 fluorophore (Invitrogen).
Statistical Analysis of Western Blots—All experiments were per-
formed in triplicate or as indicated, with error bars denoting s.e.m.
Statistical analyses were carried out with the unpaired two-sided t
test. p  0.05 (*) was considered statistically significant.
Size Exclusion Chromatography—Size exclusion chromatography
was performed on a Superose 6 10/300 GL column at 20 °C in 50 mM
HEPES pH 7.5, 150 mM NaCl, 5 mM MgCl2, 0.5% NP40, 1 mM DTT, 25
mM -Glycerophosphate, 10 M leupeptin/pepstatin. 3.5 mg cleared
cell lysates from stable HEK293 p97-WT/EQ cell lines (24 h after
induction with doxycycline) were separated into 13 fractions and
analyzed by Western blotting.
AP-SWATH Analysis—Cells were lysed on ice in HNN lysis buffer
(0.5% IGEPAL ca-630, 50 mM HEPES, pH 7.5, 150 mM NaCl, 50 mM
NaF, 200 M NaVO3, 0.5 mM PMSF, 1.2 M Avidin, and protease
inhibitor mixture (Sigma)) and centrifuged at 16,100  g for 15 min at
4 °C. Single step affinity purification from the supernatants via the
streptavidin binding peptide tag, TCA precipitation, trypsin digestion,
and solid phase extraction of peptides were performed as previously
described (30). Samples from affinity purifications of p97-wild type or
p97-E578Q, in addition to GFP control purifications were analyzed
both, in data dependent acquisition (DDA) mode for spectral library
building, and SWATH-MS mode for quantitative analysis. MS data in
DDA and SWATH-MS modes were acquired using a Sciex 5600
TripleTOF mass spectrometer interfaced to an Eksigent NanoLC Ultra
using acquisition parameters as previously described (30) with the
exception that for SWATH analysis 64 variable width precursor iso-
lation windows were used (31). Spectral library building from DDA
data was performed using the human canonical UniProt/SwissProt
database (March 2013) supplemented with common contaminants
and iRT peptide sequences containing 20,318 target and 20,283
decoy entries as described (32) except 3 search engines were used
(Tandem - version JACKHAMMER 2013.06.15, with and without k-
score plugin, and Comet 2014.02 rev. 2, post-processing and spec-
tral library building with Trans Proteomic Pipeline v4.7.0) (33–35),
semitryptic digestion was specified and 2 missed cleavages allowed,
oxidation of methionine was set as a variable modification, carbam-
idomethylation was set as a fixed modification, mass tolerance was
set to 50 ppm (precursor) and 100 ppm (fragment), the protein false
discovery was set to 5% estimated using Mayu v1.08 (iProphet prob-
ability threshold  0.554009, 0.28% PSM FDR, and 0.6% peptide
FDR), the top 5 most intense transitions per precursor including
neutrals losses were selected, and decoys for OpenSWATH analysis
were generated using the “shuffle” method. Peak lists for database
searching were generated using the qtofpeakpicker tool in Proteowiz-
ard v 3.0.11026. Only peptides with a unique mapping in the database
(proteotypic) were used for analysis. To improve coverage of the
spectral library we added DDA data from affinity purifications of 23
p97 cofactors (NSFL1C, UFD1L, NPLOC4, YOD1, PLAA, UBXN7,
ASPSCR1, FAF1, UBXN1, UBXN2B, SPRTN, NGLY1, UBXN10,
VCPIP1, ZFAND2B, UBXN11, OTUD7B, RNF31, ATXN3, UBXN2A,
UBXN6, FAF2, and SVIP).
The SWATH-MS data was analyzed using OpenSWATH (v2.1) es-
sentially as described (30, 36). FDR was controlled in the experiment-
wide context at 1% at the peptide query level and in the global
context at 1% at the peptide query and protein levels (37). Peak
groups were further aligned using the TRIC algorithm with the Lo-
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calMST and lowess options with a target FDR of 1%. Protein abun-
dances were computed using the ‘best flyer peptide’ approach by
summing the top 5 most intense fragments from the top 3 most
intense peptides using aLFQ (38, 39). After log2 tranformation and
median normalization, we prefiltered the data by first removing any
protein that was not identified in at least 2 out of 3 replicates in either
p97-WT or p97-EQ. We removed contaminant proteins by then com-
puting the median log2 fold change and t-tests (equal variance as-
sumed) between either p97-WT or p97-EQ and GFP controls where
log2 fold change 2 and p value 0.05 was considered a significant
interaction. We further insisted proteins whose median log2 abun-
dance in either p97-WT or p97-EQ must be display at least a 2-fold
increase over the maximum abundance from a set of 9 GFP controls
purifications from a previous study (30). Median log2 fold change and
t-tests were also computed between p97-EQ and p97-WT where log2
fold change  2 or  2 and p value  0.05 was considered a
significant change in the interaction of a protein with p97 between the
wild-type and mutant conditions. Missing protein abundance values
were imputed using the minimum abundance from the quantitative
matrix for calculating statistics.
Experimental Design and Statistical Rationale for AP-SWATH Ex-
periments—Samples from affinity purifications of 3 biological repli-
cates of p97 wild-type and 3 biological replicates of p97-E578Q, in
addition to 2 biological replicates of GFP control purifications (one
GFP replicate was discarded because of experimental error) were
analyzed both in data dependent acquisition (DDA) mode and
SWATH-MS mode. To improve power in contaminant filtering we
supplemented the analysis with data from 9 additional independent
biological replicate GFP control purifications. As we expected that the
effect sizes, both from a contaminant filtering perspective, and from a
wild-type versusmutant comparison perspective, should be large, we
reasoned that this level of replication would be sufficient to detect
significant changes. Multiple hits were validated by orthogonal bio-
chemical methods as described.
RESULTS
SWATH-MS Analysis of VCP/p97 Wild-type and a Sub-
strate-trapping Mutant—Previous MS-based measurements
identified a number of factors that interact with p97 or its
cofactors, but did not specifically link this analysis to ATP
hydrolysis and thus biochemical activity of p97 (41, 42). The
strategy applied in the present study was to use the sub-
strate-trapping mutant p97-E578Q (p97-EQ) as bait protein
and to quantitatively compare its interactors with those of
wild-type p97 (p97-WT). With this approach, we aimed to
specifically “freeze” p97-mediated unfolding reactions and
entangle substrates as well as associated cofactors and reg-
ulators, whose identification could reveal previously unidenti-
fied links of p97 to relevant signaling pathways. We combined
this approach with SWATH-MS analysis (43), a data inde-
pendent acquisition method that deterministically records
fragment ion spectra for all detectable peptide precursors
which are later analyzed in a targeted fashion with reference
to spectral libraries where the mass spectrometric and chro-
matographic coordinates for peptides of interest have been
established. SWATH-MS combines the advantages of data
dependent acquisition (high throughput) with those of se-
lected reaction monitoring (high reproducibility, consistency,
and dynamic range) and we have previously established the
advantages of this method for quantitative analysis of affinity
purification samples (30). We used previously described sta-
ble cell lines that express strep-tagged p97-WT or p97-EQ
upon doxycycline induction at near endogenous levels, which
integrate into endogenous p97 hexamers (see Fig. 1A for
scheme) (23).
To generate a spectral library for peptides from the proteins
of interest, we first analyzed affinity purifications of the p97-
WT, p97-EQ, and GFP control purifications by data depend-
ent acquisition (DDA) mass spectrometry. To increase the
coverage of relevant proteins in the spectral library we sup-
plemented the DDA analysis with purifications of 23 cofactors
from the p97 system. Database searching and spectral library
generation (32) was performed resulting in a spectral library
containing coordinates for 3,839 proteins represented by
36,540 uniquely mapping peptides. SWATH-MS data was
acquired for p97-WT, p97-EQ, and GFP control purifications
and quantitative data was extracted by targeted analysis
based on the spectral library resulting in a quantitative data
matrix containing 1,937 proteins (supplemental Table S1). To
filter out contaminant proteins we made a direct comparison
of p97-WT or p97-EQ with GFP control purifications that
resulted in the detection of 108 high-confidence interactions.
To determine which of these interacting proteins might be p97
substrates or otherwise modulated by the EQ mutation we
then compared quantitatively proteins co-purified in the
p97-EQ or p97-WT conditions. Of the high confidence inter-
acting proteins, 43 displayed an increase in binding to p97-EQ
(p value 0.05) by at least 2 log2, whereas 8 were reduced by
at least 2 log2 compared with p97-WT (Fig. 1B). As expected,
among the proteins with the strongest increase was PLAA, a
cofactor known to specifically bind p97-EQ both in cell lysates
and with purified proteins (23, 44). Moreover, we detected
other established and previously biochemically validated p97
cofactors such as SVIP, UBXN6/UBXD1, UBXN7, FAF1, and
UBXN2B/p37 (22). In addition, factors involved in p97-regu-
lated ERAD such as AMFR/gp78, FAF2/UBXD8, UFD1L/Ufd1,
NPLOC4/Npl4, SEL1L and UBAC2, were consistently in-
creased with p97-EQ, suggesting that they were trapped in
the segregation processes along with ubiquitinated sub-
strates. Not all known established cofactors were increased in
p97-EQ suggesting functional differences in how they coop-
erate with p97. Even related cofactors such as the SEP do-
main-containing proteins UBXN2B/p37 (7-fold increase),
UBXN2A/UBXD4 (3.7-fold decrease) and NSFL1C/p47 (no
change) showed largely divergent binding preference.
Of note, the AP-SWATH analysis allowed a high dynamic
range of detection covering 4 orders of magnitude from the
bait protein p97 and known abundant cofactors such as Ufd1
to low abundant proteins lacking dedicated p97-binding do-
mains (Fig. 1C). Thus, our analysis detected many additional
interactors not identified in p97 pulldowns of other studies
(41, 45). The comparison between our results and selected
previous studies (41, 46, 47) is shown in supplemental Fig. S1
SWATH-MS of p97 Reveals ISR Signaling Function
1298 Molecular & Cellular Proteomics 17.7
 at QUEENS UNIV on August 9, 2019
http://w
w
w
.m
cponline.org/
D
ow
nloaded from
 
Input 10% VCP/p97 pulldown
DOX + +- -
WB:
VCP/p97
w
ild
-ty
pe
w
ild
-ty
pe
E
Q
E
Q
stable VCP/p97 myc-strep HEK293
WT EQ
streptactin purification
SWATH-MS
Work pipeline
+ +- -
w
ild
-ty
pe
w
ild
-ty
pe
E
Q
E
Q
A
B
C
VCP/p97 interacting protein no.
SWATH-MS of p97 Reveals ISR Signaling Function
Molecular & Cellular Proteomics 17.7 1299
 at QUEENS UNIV on August 9, 2019
http://w
w
w
.m
cponline.org/
D
ow
nloaded from
 
(data in supplemental Table S2). Among the low abundance
interactors were certain ubiquitin ligases or ligase compo-
nents such as RNF185, MUL1, or the CUL2 adapter FEM1B
that were specifically trapped with the mutant with log2-fold
increases ranging from 2 to 9 indicating that they cooperate
intimately with p97.
Validation of Differential Cofactor Binding and Ubiquitin Li-
gase Interaction—We first validated the AP-SWATH results
using gel filtration of lysate from p97-WT and p97-EQ ex-
pressing HEK293 cells for known p97 cofactors with available
antibodies. As expected, p97-EQ was partially shifted to
higher molecular weight fractions compared with p97-WT
indicating that it was engaged more tightly in larger com-
plexes (Fig. 2A). Importantly, PLAA and UBXD1 quantitatively
shifted to high molecular weight fractions and UBXD7 at least
in part co-migrated with p97 fractions. p47 was not bound to
p97 under the stringent conditions of gel filtration, as ob-
served earlier (48). We therefore tested the interaction of p47
and the other SEP domain proteins by co-immunoprecipita-
tion of p97-WT and p97-EQ followed byWestern blotting. This
confirmed that p47 binding was unchanged, p37 was in-
creased and UBXD4 was decreased in p97-EQ pulldowns
compared with p97-WT (Fig. 2B). These results validate the
results of the AP-SWATH analysis and confirm an intriguing
heterogeneity among cofactors with respect to binding in
substrate-trapping complexes.
We next tested low abundance interactors with highly in-
creased binding to p97-EQ according to the AP-SWATH anal-
ysis. This included the ubiquitin ligases that have not been
linked to p97 such as the mitochondrial MUL1 and RNF185
(both 8 log2 fold increases). MUL1 and RNF185 have both
been associated with regulation of mitophagy, whereas
RNF185 has also been linked to ERAD (49, 50, 51). Overex-
pression in p97-WT or p97-EQ expressing cells followed by
co-immunoprecipitation of the candidates confirmed in-
creased binding to p97-EQ in both cases (Fig. 2C and 2D).
This was also shown in HeLa cells, where correct subcellular
localization of overexpressed MUL1 and RNF185 to mito-
chondria and ER, respectively (50, 51), was confirmed by
microscopy (supplemental Fig. S2A–S2D). In contrast, the
ubiquitin ligase UBE4B was detected but did not show sig-
nificantly differential binding in the AP-SWATH analysis and
was not increased by the mutation in co-immunoprecipita-
tions (Fig. 2E). Again, expected nuclear localization of the
overexpressed UBE4B was confirmed by microscopy (sup-
plemental Fig. S2E).
p97 Targets the Ubiquitinated Protein Phosphatase-1 Reg-
ulator CReP/PPP1R15B—Among the low abundance interac-
tors, a number of proteins were identified that were not known
to be p97 cofactors or ubiquitin regulators, and could there-
fore constitute novel substrates (Fig. 1B and 1C and supple-
mental Table S1). Of note, glutamine synthetase (annotated as
GLUL), which was identified to be increased by 30-fold in
our screen, was only recently described as a target of p97-
mediated degradation (52). Other strong candidates included
membrane trafficking or signaling regulators such as SHKBP1
(SH3KBP1 binding protein 1), WLS (wntless Wnt ligand se-
cretion mediator), EPSTI1 (Epithelial-stromal interaction pro-
tein 1), TRAFD1 (TRAF-type zinc finger domain containing
protein 1) as well as the unconventional myosin MYO5C. We
focused on CReP/PPP1R15B, which was exclusively de-
tected in p97-EQ pulldowns (Fig. 1B and 1C), because it is a
modulator of the integrated stress response and has not been
linked to p97. Notably, in the AP-SWATH analysis, only a
single proteotypic peptide was detected which, however, dis-
played a consistent and confident signal in p97-EQ isolations
(median protein level q-value  2.45E-04) but was not de-
tected in p97-WT (supplemental Fig. S3). Further, according
to PeptideAtlas (53), the single peptide we detected is ranked
as the highest for predicted observability and among the top
few peptides in empirical observations in mass spectrometry
experiments where CReP was detected. This is consistent
with the view that CReP is very low abundant in our p97-EQ
affinity purification sample and can only be observed by the
best MS responding peptide. To validate this result, we first
immunoprecipitated endogenous CReP from cell lysate ex-
pressing p97 variants and confirmed binding to p97-EQ, but
not p97-WT (Fig. 3A). Efficient extraction of endogenous
CReP in our lysate was confirmed (supplemental Fig. S4A).
The CReP antibody detected a second faster-migrating band
that was confirmed to be nonspecific using siRNA-mediated
depletion of CReP (supplemental Fig. S4B).
The Ufd1-Npl4 heterodimer is the major p97 adapter for
polyubiquitinated substrate proteins that are destined for deg-
radation in the proteasome (16, 22). We therefore asked
whether it is associated also with CReP from the p97-EQ
FIG. 1. Comparative SWATH-MS of VCP/p97 wild-type and the substrate-trapping mutant, VCP/p97-E578Q, identifies differential
binding of subsets of cofactors, ubiquitin ligases and potential substrates. A, Work flow. Isogenic stable HEK293 cells were induced to
express strep-tagged VCP/p97 wild-type (p97-WT) or VCP/p97-E578Q (p97-EQ). p97 was affinity-purified from detergent extracts and
associated proteins analyzed by SWATH-MS. Western blot analysis of overexpressed and endogenous p97 (indicated by arrows). B,
Scatterplot of interactors as identified by SWATH analysis. The Y-axis represents the fold change ratio of VCP/p97-EQ versus VCP/p97-WT.
The X-axis represents the fold change of VCP/p97-WT or VCP/p97-EQ versus GFP-pulldown controls. p values for contaminant filtering and
EQ/WT comparison visualized as indicated. Individual candidates mentioned in the text are annotated. See supplemental Table S1 for full list.
The proteins falling along the diagonal lines in either the upper right or lower right quadrant are those which have only been identified and
quantified in either the VCP/p97-EQ, or VCP/p97-WT purifications, respectively. C, Plot representing the 108 high confidence hits arranged
according to abundance in VCP/p97-WT and changes in VCP/p97-EQ are indicated by arrows. Note the high dynamic range over 4 log10.
Individual candidates mentioned in the text are annotated. Observations of a given protein interaction in previous studies are annotated as
indicated.
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lysates. Indeed, Western blot analysis revealed association
with Ufd1 and Npl4 (Fig. 3A). Consistent with that, we also
detected polyubiquitination in immunoprecipitations of over-
expressed CReP (Fig. 3B). Expected localization of the over-
expressed CReP was confirmed by fluorescence microscopy
(supplemental Fig. S4C). Importantly, the ubiquitination signal
increased after inhibition of p97 or the proteasome (Fig. 3B),
suggesting that ubiquitinated CReP is turned over by the
proteasome with the help of p97 and, thus, that CReP is a
substrate of p97-Ufd1-Npl4.
The p97-Ufd1-Npl4 Complex is Required for Constitutive
Degradation of CReP—To further explore this, we first ana-
lyzed the role of p97 in constitutive degradation of CReP. A
cycloheximide (CHX) chase in control cells confirmed its high
turnover rate (9), as CReP levels dropped to undetectable
levels within 3 h (Fig. 4A and 4B). Crucially, pharmacological
inactivation of p97 with two unrelated inhibitors, NMS-873 or
CB-5083 (17, 18), stabilized CReP under these conditions
(Fig. 4A–4C). Likewise, induction of the dominant-negative
p97-EQ trapping mutant in our stable cell line again signifi-
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FIG. 2. Validation of differential binding to cofactors and additional interactors. A, Gel filtration of lysate from cells expressing p97-WT
or p97-EQ. Fraction numbers and antibodies used for Western blotting are indicated. Note the shift of p97, PLAA, UBXD1 and UBXD7 in
p97-EQ lysate toward the high molecular weight fraction, whereas p47 remain unbound under the stringent conditions. B, Affinity purification
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cantly delayed degradation of CReP compared with p97-WT
induction (Fig. 4D). To clarify whether the Ufd1-Npl4 adapter
was required, we depleted Ufd1, or the alternative p47 cofac-
tor as control with established siRNAs. Depletion of Ufd1, but
not of p47, over 2 days already led to an increase of CReP
levels compared with control depletion (Fig. 4E and 4F). More-
over, it delayed degradation in the CHX chase, whereas de-
pletion of p47 had no effect (Fig. 4E and 4F). This was con-
firmed with an independent Ufd1 siRNA (supplemental Fig.
S5). These data suggest that the Ufd1-Npl4 adapter assists
p97 in the constitutive degradation of CReP.
p97-Ufd1-Npl4 Facilitated Degradation is Essential for the
Drop of CReP Levels and a Robust Increase in eIF2 Phos-
phorylation after UV and Arsenite Treatment—We next sought
to clarify the relevance of p97-Ufd1-Npl4-mediated degrada-
tion of CReP in the integrated stress response. Under non-
stress conditions, the PP1-CReP complex constitutively de-
phosphorylates eIF2 to antagonize stress kinases and
maintain protein synthesis (9). Although CReP levels remain
largely stable upon ER stress (9), CReP is quantitatively de-
graded upon exposure to UV (54). We confirmed stable levels
upon thapsigargin and tunicamycin treatments, as well as
CReP degradation upon UV exposure (Fig. 5A, 5B and sup-
plemental Fig. S6A). In addition, we observed rapid CReP
degradation also upon arsenite treatment (supplemental Fig.
S6A). UV exposure did not appear to accelerate the CReP
degradation rate when compared with addition of CHX, and
the two treatments were not additive (supplemental Fig. S6B),
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FIG. 4. p97 and Ufd1 are essential for constitutive degradation of CReP. A, Cycloheximide (CHX) chase experiments in the presence of
the p97 inhibitor NMS-873 (5 M) or DMSO alone. Cells were lysed at indicated time points after CHX addition and lysates subjected to Western
blotting. Tubulin was probed as loading control. UT  untreated. B, Quantification of chemiluminescence in three independent experiments.
CReP Western blotting signals were normalized to loading control and values displayed relative to those in untreated (UT) cells. Error bars,
s.e.m., (*) p value  0.05. C, As in (A), but with the unrelated competitive p97 inhibitor CB-5083 (5 M). D, CHX chase experiments as in (A)
were conducted in cells expressing p97-WT or the dominant-negative p97-EQ. Cells at time point 0 were mock (DMSO) treated. E, CHX chase
experiments were perfomed in cells treated with control siRNA, or siRNA directed against Ufd1 or p47 for 48 h. Depletion efficiency of Ufd1
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suggesting that the decline of CReP levels under stress is a
result of both degradation and inhibition of CReP synthesis.
Of note, the degradation of CReP after UV exposure was
largely inhibited by NMS-873, and NMS-873 affected degra-
dation also after arsenite treatment (Fig. 5A, 5B and supple-
mental Fig. S6C), demonstrating that p97 is essential for the
stress-induced quantitative removal of CReP. In both condi-
tions, stress-induced phosphorylation of eIF2 was attenu-
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ated when p97 was inhibited by NMS-873 (Fig. 5A, and sup-
plemental Fig. S6C), correlating with the failure to degrade
CReP and, thus, with persistent PP1-CReP activity that an-
tagonizes eIF2 phosphorylation.
We next monitored the effect of Ufd1 depletion on stress-
induced CReP degradation. Ufd1 depletion delayed CReP
degradation after UV irradation (Fig. 5C and 5D) showing that
Ufd1 not only assists p97 in the constitutive degradation, but
also in the stress-induced degradation of CReP. This mirrored
the effect of depleting the ubiquitin ligase component -TrCP
(Fig. 5C), which has previously been shown to trigger CReP
degradation (54–57). Of note, the stress-induced induction of
eIF2 phosphorylation was attenuated in Ufd1 and -TrCP-
depleted cells (Fig. 5C and 5E), again correlating with the
delayed degradation of CReP. Thus, the role of the p97-Ufd1-
Npl4 complex in facilitating CReP degradation is critical for
the timely decline of CReP levels after cellular stress to ensure
robust eIF2 phosphorylation and thereby to enforce the in-
tegrated stress response that attenuates protein synthesis.
DISCUSSION
VCP/p97 has fundamental and far-reaching roles in main-
taining protein homeostasis particularly under cellular stress
conditions. In this study, we combined AP-SWATH with the
use of a p97 substrate-trapping mutant to further explore the
complexity of the p97 system and how it achieves this task.
Biochemical validation of the acquired AP-SWATH data dem-
onstrated the high accuracy of the results reflected in differ-
ential binding of known cofactors and additional factors over
4 orders of magnitude of dynamic range demonstrating the
suitability and reliability of AP-SWATH for comparison of in-
teractomes from different conditions. The increased dynamic
range of quantification, in combination with the use of a
substrate-trapping mutant, has allowed us to substantially
expand on the set of AP-MS derived p97 protein interactions
with respect to either a recent large-scale protein interaction
screen (47), or a study focused on p97 (41).
We found that many but not all known p97 cofactors are
trapped by the mutant pointing to differences in how cofac-
tors cooperate with p97 despite similar interaction domains.
In addition, a number of other factors including E3 ubiquitin
ligases were specifically trapped by p97-EQ. This likely re-
flects the formation of substrate-induced, transient p97-co-
factor complexes that only disassemble when the substrate is
appropriately unfolded or segregated by p97. Consistent with
this notion, we find many proteins involved in ERAD that were
trapped ranging from the relevant ligases on the cytosolic side
up to SEL1L on the luminal side of the ER. This suggests that
p97-EQ stabilizes transient protein interactions in ERAD by
“freezing” the substrate in the process of retro-translocation.
Likewise, we find that p97-EQ strongly traps ubiquitin ligases
such as MUL1 or RNF185, which have both been associated
with mitochondrial quality control (49, 50). This points to in-
triguing mechanisms that link ubiquitin-modification with un-
folding also in this pathway.
Although the p97 substrate proteome is highly complex
with thousands of heterogeneous substrates in different path-
ways, the AP-SWATH approach with its high dynamic range
also identified individual substrate proteins. Among them,
glutamine synthetase was only recently shown to be a direct
target of p97 (52). Other highly scoring and low abundant
candidates still need to be confirmed, such as the modulator
of EGF receptor transport, SHKBP1, a transport factor of Wnt
proteins, WLS, the unconventional MYO5C or the NFkB reg-
ulators TRAFD1 or EPSTI1. They represent novel and prom-
ising directions for understanding p97 function in signaling
and membrane transport. Of note, our approach led us to
discover the eIF2-specific PP1 regulator CReP as a sub-
strate of p97. The evidence for CReP being a direct substrate
is compelling as we show interaction of CReP with p97 and
the Ufd1-Npl4 adapter, p97-Ufd1-Npl4 dependent degrada-
tion of CReP, and the accumulation of ubiquitinated CReP in
the absence of p97 activity. Importantly, this finding reveals a
direct involvement of p97 in stress signaling as an unantici-
pated aspect of p97 physiology. Phosphorylation of eIF2 is
fine-tuned by stress kinases and the antagonizing PP1-CReP
complex. CReP has a high constitutive turnover to facilitate
responsiveness to regulation. We demonstrate that p97 en-
sures the high turnover and thus balances CReP levels in
unperturbed cells. Moreover, we show here that stress-in-
duced quantitative degradation of CReP requires the p97-
Ufd1-Npl4 complex to allow robust phosphorylation of eIF2
in stressed cells, demonstrating that p97 enforces the inte-
grated stress response on the level of signaling.
Intriguingly, CReP degradation is triggered by the SCF--
TrCP ubiquitin ligase complex (54–57) as is degradation of
two other p97-substrates, IkB and CDC25A (58, 59). This
reveals how p97 function is intertwined with stress signaling.
DNA-damage induced degradation of CDC25A halts cell cy-
cle progression, whereas CReP degradation is part of the
integrated stress response that governs global protein syn-
thesis through regulation of eIF2 phosphorylation. p97 has
therefore an unanticipated dual role in maintaining cellular
homeostasis (see model Fig. 5F). On one hand, it ensures
clearance of damaged and misfolded proteins in a variety of
pathways and compartments including the ER. This prevents
activation of stress kinases such as PERK that phosphorylate
eIF2 and attenuate translation. On the other hand, p97 en-
sures constitutive turnover of the eIF2 phosphatase compo-
nent CReP. This is important to balance CReP activity in
unperturbed cells, but also to ensure the timely drop in CReP
levels under certain stresses to enforce phosphorylation of
eIF2. The quantitative removal of cellular CReP appears to
be the result of both the efficient turnover by p97 and a block
of CReP synthesis. Inhibitors of eIF2 dephosphorylation
have been shown to protect against protein stress (60, 61).
Conversely, p97 inhibitors aimed at triggering a proteostasis
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crisis and cell death in cancer cells (17, 62) will therefore
function by perturbing both branches, bulk degradation of
damaged proteins and protective signaling of the integrated
stress response.
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